Table 1 Mendelian randomization results of coronary heart disease and myocardial infarction

From: Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease

CpG

Phenotype

Chr

Gene

Number of independent cis-meQTLs

IVW MR test OR

IVW MR test 95% CI

IVW MR test P-value

IVW MR test Bonferroni-corrected P-value

Heterogeneity test P-value

Pleiotropy test P-value

cg09803321

CHD /MI

10

NT5C2

3

0.28

0.20–0.38

3.75E−15

5.59E−11

0.98

0.83

cg12555086

CHD /MI

10

LIPA

4

0.42

0.32–0.54

1.41E−11

2.10E−07

0.62

0.37

cg18534077

CHD

10

AS3MT

8

0.14

0.08–0.26

6.02E−11

8.98E−07

0.26

0.50

cg02493740

CHD

2

VAMP5

7

0.33

0.23–0.48

1.91E−09

2.85E−05

0.53

0.81

cg16306978

CHD

2

APOB

3

2.46

1.83–3.30

2.09E−09

3.12E−05

0.73

0.48

cg00908766

CHD /MI

1

CELSR2

5

2.18

1.66–2.87

4.34E−08

6.47E−04

0.12

0.55

cg00540400

CHD /MI

15

 

3

3.00

2.03–4.45

5.99E−08

8.93E−04

0.38

0.57

cg16513277

CHD /MI

17

SMG6

3

0.06

0.02–0.17

1.99E−07

2.97E−03

0.62

0.43

cg21433558

CHD

17

CNTNAP1

5

2.69

1.82–3.98

6.73E−07

1.00E−02

0.70

0.36

cg14037218

CHD

1

ADAMTSL4

3

0.14

0.07–0.31

1.20E−06

1.79E−02

0.81

0.53

cg24267699

CHD

9

ABO

4

2.89

1.88–4.44

1.34E−06

2.00E−02

0.61

0.47

cg21692620

MI

17

CNTNAP1

4

0.26

0.15–0.45

1.41E−06

2.10E−02

0.57

0.57

  1. For CpGs that tested causal for both MI and CHD, only the MR results for CHD are shown in this table. The full MR results are shown in Supplementary Data 3
  2. Bonferroni-corrected P-value is corrected for the number of CpGs having ≥3 independent cis-meQTLs (N = 14,910)
  3. Independent cis-meQTLs were defined using LD r2 < 0.01